Are you Dr. Hall?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 10 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-8596Fax+1 919-843-5515
Summary
- Dr. Colin Hall, MD is a board certified neurologist in Chapel Hill, North Carolina. He is currently licensed to practice medicine in North Carolina.
Education & Training
University of North Carolina HospitalsResidency, Neurology, 1969 - 1972- University of North Carolina HospitalsResidency, Surgery, 1967 - 1969
University of Aberdeen Faculty of MedicineClass of 1966
Certifications & Licensure
NC State Medical License 1973 - 2013- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 9 citationsDistal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1–Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource...Alyssa Vecchio, Christina M. Marra, Jeffrey T. Schouten, Hongyu Jiang, Johnstone Kumwenda
Clinical Infectious Diseases. 2020-06-24 - 13 citationsHuman Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological Dysfunction.Kevin Robertson, Bibilola D. Oladeji, Hongyu Jiang, Johnstone Kumwenda, Khuanchai Supparatpinyo
Clinical Infectious Diseases. 2019-05-02 - 13 citationsHuman Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings.Kevin Robertson, Hongyu Jiang, Johnstone Kumwenda, Khuanchai Supparatpinyo, Christina M. Marra
Clinical Infectious Diseases. 2018-09-13
Grant Support
- Neurological Response To HaartNational Center For Research Resources2004–2007
- Cerebrospinal Fluid HIV-1 And Cognitive Function In Patients Receiving TherapyNational Center For Research Resources2004–2006
- Selegiline Transdermal System In Hiv-Associated Cognitive ImpairmentNational Center For Research Resources2004–2005
- Neurological Response To HaartNational Institute Of Mental Health2000–2004
- Effects Of HIV On The Nervous System In WomenNational Center For Research Resources1997–2004
- Recombinant Human Nerve Growth Factor In HIV Associated NeuropathyNational Center For Research Resources1999–2002
- Phase III Trial To Evaluate The Safety And Efficacy Of 159u89 In HIV-1National Center For Research Resources1998–2002
- Recombinant Human Nerve Growth Factor For The Treatment Of HIV InfectionNational Center For Research Resources1997–2002
- Cytosine Arabinoside For Multifocal Leukoencephalopathy In HIV InfectionNational Institute Of Neurological Disorders And Stroke1997–2001
- Neuroimaging In HIV InfectionNational Institute Of Mental Health1997–2001
- Lamictal In Adult Subjects W/ HIV Associated NeuropathyNational Center For Research Resources2000
- Evaluate The Safety And Efficacy Of 159u89 In HIV-1 PTSNational Center For Research Resources2000
- HIV Effects On The Nervous System In WomenNational Institute Of Neurological Disorders And Stroke1996–2000
- Study OC Amitriptyline And Mexiletine For Painful Neuropathy In HIV (Actg 242)National Center For Research Resources1997
- Antiretroviral Medication Alone To Antiretroviral Medication In PMLNational Center For Research Resources1997
- Amitriptyline And Mexiletine For Painful Neuropathy In Hiv--Actg 242National Center For Research Resources1996
- Antiretroviral Medication Alone To Antiretroviral Medication And ARA-CNational Center For Research Resources1995–1996
- Study Of Oxandrolone For HIV 1 Associated Myopathy/Muscle WeaknessNational Center For Research Resources1995
- Proposal For An AIDS Dementia CenterNational Institute Of Neurological Disorders And Stroke1988–1992
